These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 16596462

  • 1. Treatment of osteoporosis with TheraCyte-encapsulated parathyroid cells: a study in a rat model.
    Chou FF, Huang SC, Chen SS, Wang PW, Huang PH, Lu KY.
    Osteoporos Int; 2006; 17(6):936-41. PubMed ID: 16596462
    [Abstract] [Full Text] [Related]

  • 2. Effect of TheraCyte-encapsulated parathyroid cells on lumbar fusion in a rat model.
    Chen SH, Huang SC, Lui CC, Lin TP, Chou FF, Ko JY.
    Eur Spine J; 2012 Sep; 21(9):1734-9. PubMed ID: 22766833
    [Abstract] [Full Text] [Related]

  • 3. [The replacement therapy of rPTH(1-84) in established rat model of hypothyroidism].
    Ding Z, Li T, Liu Y, Xiao S.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Dec; 50(12):1020-5. PubMed ID: 26888134
    [Abstract] [Full Text] [Related]

  • 4. The use of simvastatin with aromasin in an ovariectomized rat model: effects on the skeletal system.
    Chen SH, Chou FF, Ko JY.
    Chang Gung Med J; 2010 Dec; 33(5):509-14. PubMed ID: 20979701
    [Abstract] [Full Text] [Related]

  • 5. Parathyroidectomy can improve bone mineral density in patients with symptomatic secondary hyperparathyroidism.
    Chou FF, Chen JB, Lee CH, Chen SH, Sheen-Chen SM.
    Arch Surg; 2001 Sep; 136(9):1064-8. PubMed ID: 11529832
    [Abstract] [Full Text] [Related]

  • 6. [Experimental study on effect of anhydroicaritin phytosomes in preventing and treating bone loss and enhancing bone quality in ovariectomized osteoporosis rats].
    Wu MS, Zhao SZ, Ren LZ, Wang R, Bai X, Han HW, Li B.
    Zhongguo Zhong Yao Za Zhi; 2013 Jul; 38(13):2163-8. PubMed ID: 24079247
    [Abstract] [Full Text] [Related]

  • 7. Atorvastatin enhances bone density in ovariectomized rats given 17beta-estradiol or human parathyroid hormone(1-34).
    Kawane T, Terashima S, Kurahashi I, Yanagawa T, Yoshida H, Horiuchi N.
    Endocrine; 2004 Jul; 24(2):121-9. PubMed ID: 15347837
    [Abstract] [Full Text] [Related]

  • 8. Effects of treatment with parathyroid hormone 1-84 on quantity and biomechanical properties of thoracic vertebral trabecular bone in ovariectomized rhesus monkeys.
    Fox J, Newman MK, Turner CH, Guldberg RE, Varela A, Smith SY.
    Calcif Tissue Int; 2008 Mar; 82(3):212-20. PubMed ID: 18297227
    [Abstract] [Full Text] [Related]

  • 9. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J, Miller MA, Newman MK, Metcalfe AF, Turner CH, Recker RR, Smith SY.
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [Abstract] [Full Text] [Related]

  • 10. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
    Shen V, Birchman R, Wu DD, Lindsay R.
    J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
    [Abstract] [Full Text] [Related]

  • 11. [Effect of total flavones of Epimedium leptorrhizum on osteoporosis in ovariectomized rats].
    Cao CY, Liu T, Hui LQ, Hao R.
    Zhongguo Zhong Yao Za Zhi; 2014 May; 39(10):1913-7. PubMed ID: 25282905
    [Abstract] [Full Text] [Related]

  • 12. Long-term changes in bone mineral and biomechanical properties of vertebrae and femur in aging, dietary calcium restricted, and/or estrogen-deprived/-replaced rats.
    Jiang Y, Zhao J, Genant HK, Dequeker J, Geusens P.
    J Bone Miner Res; 1997 May; 12(5):820-31. PubMed ID: 9144349
    [Abstract] [Full Text] [Related]

  • 13. Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial.
    Lane NE, Sanchez S, Modin GW, Genant HK, Pierini E, Arnaud CD.
    J Bone Miner Res; 2000 May; 15(5):944-51. PubMed ID: 10804025
    [Abstract] [Full Text] [Related]

  • 14. [Effects of salmon calcitonin in treatment of osteoporosis in patients undergoing dialysis].
    Wang SX, Li H.
    Zhonghua Yi Xue Za Zhi; 2008 Feb 05; 88(6):387-90. PubMed ID: 18581891
    [Abstract] [Full Text] [Related]

  • 15. Salmon calcitonin in prevention of osteoporosis in maintenance dialysis patients.
    Wang SX, Li H.
    Chin Med J (Engl); 2008 Jul 20; 121(14):1280-4. PubMed ID: 18713548
    [Abstract] [Full Text] [Related]

  • 16. Time-course of vertebral and femoral bone loss in rats administered gonadotrophin-releasing hormone agonist.
    Kurabayashi T, Fujimaki T, Yasuda M, Yamamoto Y, Tanaka K.
    J Endocrinol; 1993 Jul 20; 138(1):115-25. PubMed ID: 7852882
    [Abstract] [Full Text] [Related]

  • 17. The effects of parathyroid hormone, alendronate, or both in men with osteoporosis.
    Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM.
    N Engl J Med; 2003 Sep 25; 349(13):1216-26. PubMed ID: 14500805
    [Abstract] [Full Text] [Related]

  • 18. Effects of alendronate on bone mineral density and bone metabolic markers in patients with liver transplantation.
    Atamaz F, Hepguler S, Akyildiz M, Karasu Z, Kilic M.
    Osteoporos Int; 2006 Sep 25; 17(6):942-9. PubMed ID: 16550299
    [Abstract] [Full Text] [Related]

  • 19. [Effect of estrogen on the expression of matrix GLA protein in ovariectomized SD rats].
    Chen XY, Jiang XH, Lai XY, Fang XN, Yang Y.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov 25; 47(11):833-8. PubMed ID: 23302124
    [Abstract] [Full Text] [Related]

  • 20. Effects of human parathyroid hormone 1-34 on bone loss and lumbar intervertebral disc degeneration in ovariectomized rats.
    Luo Y, Li SY, Tian FM, Song HP, Zhang YZ, Zhang L.
    Int Orthop; 2018 May 25; 42(5):1183-1190. PubMed ID: 29442158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.